Insights

Innovative Drug Discovery PsychoGenics has recently launched eCube, an AI-enabled platform designed for drug discovery, highlighting their focus on leveraging advanced technology to accelerate research, which presents opportunities to offer complementary AI solutions or integrative services.

Strong Funding and Revenue With a revenue range of up to 100 million dollars and recent SBIR grant funding of 3 million dollars, PsychoGenics demonstrates financial stability and growth potential, making them a promising client for investment in advanced research tools and collaborations.

Collaborative Partnerships Recent collaborations with Carnegie Mellon University and Sunovion Pharmaceuticals indicate a strategic openness to partnerships, providing avenues to propose joint ventures, specialized research services, or co-development projects tailored to CNS and orphan disorder treatments.

Expanding Research Capabilities PsychoGenics’ extensive portfolio of disease models and advanced capabilities such as electrophysiology and behavioral testing suggest ongoing expansion and need for innovative solutions, offering potential for sales of specialized research equipment or software.

Market Focus on CNS and Orphan Disorders Their dedication to CNS and orphan disorder research positions PsychoGenics within high-demand, specialized markets where tailored, innovative solutions and strategic support could strengthen their research outcomes and foster long-term vendor relationships.

PsychoGenics Tech Stack

PsychoGenics uses 8 technology products and services including Shopify, Lightbox, Slick, and more. Explore PsychoGenics's tech stack below.

  • Shopify
    E-commerce
  • Lightbox
    Javascript Libraries
  • Slick
    Javascript Libraries
  • scikit-learn
    Machine Learning
  • Java
    Programming Languages
  • X-Content-Type-Options
    Web & Portal Technology
  • WP Featherlight
    Web Platform Extensions
  • Kadence WP Blocks
    Web Platform Extensions

Media & News

PsychoGenics's Email Address Formats

PsychoGenics uses at least 1 format(s):
PsychoGenics Email FormatsExamplePercentage
First.Last@psychogenics.comJohn.Doe@psychogenics.com
89%
FLast@psychogenics.comJDoe@psychogenics.com
9%
F_Last@psychogenics.comJ_Doe@psychogenics.com
1%
Last@psychogenics.comDoe@psychogenics.com
1%

Frequently Asked Questions

Where is PsychoGenics's headquarters located?

Minus sign iconPlus sign icon
PsychoGenics's main headquarters is located at 215 College Road Paramus, New Jersey 07652 United States. The company has employees across 2 continents, including North AmericaEurope.

What is PsychoGenics's official website and social media links?

Minus sign iconPlus sign icon
PsychoGenics's official website is psychogenics.com and has social profiles on LinkedInCrunchbase.

What is PsychoGenics's NAICS code?

Minus sign iconPlus sign icon
PsychoGenics's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does PsychoGenics have currently?

Minus sign iconPlus sign icon
As of February 2026, PsychoGenics has approximately 165 employees across 2 continents, including North AmericaEurope. Key team members include Chief Technology Officer: D. B.Chief Financial Officer: A. K.Chief Research Officer (cro): A. G.. Explore PsychoGenics's employee directory with LeadIQ.

What industry does PsychoGenics belong to?

Minus sign iconPlus sign icon
PsychoGenics operates in the Research Services industry.

What technology does PsychoGenics use?

Minus sign iconPlus sign icon
PsychoGenics's tech stack includes ShopifyLightboxSlickscikit-learnJavaX-Content-Type-OptionsWP FeatherlightKadence WP Blocks.

What is PsychoGenics's email format?

Minus sign iconPlus sign icon
PsychoGenics's email format typically follows the pattern of First.Last@psychogenics.com. Find more PsychoGenics email formats with LeadIQ.

How much funding has PsychoGenics raised to date?

Minus sign iconPlus sign icon
As of February 2026, PsychoGenics has raised $3M in funding. The last funding round occurred on Aug 28, 2024 for $3M.

PsychoGenics

Research ServicesNew Jersey, United States51-200 Employees

PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next generation of treatments for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development.

We are known for our cutting-edge translational approach to research, our customized solutions, the breadth and quality of our work, as well as for our ability to identify statistically relevant phenotypic changes that help our clients quantify the efficacy of their treatments before they move into the clinic.

With an extensive portfolio of highly predictive disease models and unparalleled experience performing studies for biopharmaceutical companies of all sizes, we enable clients to deliver much needed superior clinical candidates to patients.

Our capabilities include behavioral testing, electrophysiology, translational EEG, quantitative histology, molecular biology, and microdialysis. We offer a variety of validated mouse models including in-licensed transgenic models that support research in areas such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, autism spectrum disorders, psychosis and schizophrenia, spinal muscular atrophy, muscular dystrophy and a broad array of pain models.

Section iconCompany Overview

Headquarters
215 College Road Paramus, New Jersey 07652 United States
NAICS Code
5417 - Scientific Research and Development Services
Employees
51-200

Section iconFunding & Financials

  • $3M

    PsychoGenics has raised a total of $3M of funding over 3 rounds. Their latest funding round was raised on Aug 28, 2024 in the amount of $3M.

  • $50M$100M

    PsychoGenics's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $3M

    PsychoGenics has raised a total of $3M of funding over 3 rounds. Their latest funding round was raised on Aug 28, 2024 in the amount of $3M.

  • $50M$100M

    PsychoGenics's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.